Causal effects of endometriosis stages and locations on menstruation, ovulation, reproductive function, and delivery modes: a two-sample Mendelian randomization study.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): Shen L;Shen L;Shen L;Shen L; Li J; Li J; Zhang H; Zhang H; Zhao Y; Zhao Y
  • Source:
    Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2024 Aug 02; Vol. 15, pp. 1328403. Date of Electronic Publication: 2024 Aug 02 (Print Publication: 2024).
  • Publication Type:
    Journal Article
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE
    • Publication Information:
      Original Publication: [Lausanne : Frontiers Research Foundation]
    • Subject Terms:
    • Abstract:
      Background: Endometriosis is a chronic inflammatory disease of women during their reproductive years. The relationship between the severity and location of endometriosis and menstruation, ovulation, reproductive function, and mode of delivery remains unclear.
      Methods: We explored the association between the various phenotypes of endometriosis and menstruation, ovulation, reproductive function, and mode of delivery, using two-sample Mendelian randomization (MR) and summary data on endometriosis stages and locations from the FinnGen consortium and women's menstruation, ovulation, reproductive function, and mode of delivery from OpenGWAS and ReproGen. Inverse-variance weighting was used for the primary MR analysis. In addition, a series of sensitivity analyses, confounding analyses, co-localization analyses, and multivariate MR analyses were performed.
      Results: MR analysis showed a negative effect of moderate to severe endometriosis on age at last live birth (OR = 0.973, 95% CI: 0.960-0.986) and normal delivery (OR = 0.999, 95% CI: 0.998-1.000; values for endpoint were excluded), ovarian endometriosis on age at last live birth (OR = 0.976, 95% CI: 0.965-0.988) and normal delivery (OR = 0.999, 95% CI: 0.998-1.000; values for endpoint were excluded), and fallopian tubal endometriosis on excessive irregular menstruation (OR = 0.966, 95% CI: 0.942-0.990). Bidirectional MR analysis showed that age at menarche had a negative causal effect on intestinal endometriosis (OR = 0.417, 95% CI: 0.216-0.804). All MR analyses were confirmed by sensitivity analyses, and only the genetic effects of moderate to severe endometriosis on normal delivery and age at last live birth were supported by co-localization evidence.
      Conclusion: Our findings deepen the understanding of the relationship between various types of endometriosis and menstruation, ovulation, reproductive function, and mode of delivery and clarify the important role of moderate to severe endometriosis.
      Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
      (Copyright © 2024 Shen, Li, Zhang and Zhao.)
    • References:
      Genet Epidemiol. 2013 Nov;37(7):658-65. (PMID: 24114802)
      Genome Biol. 2021 Jan 13;22(1):32. (PMID: 33441155)
      Elife. 2018 May 30;7:. (PMID: 29846171)
      Int J Fertil Steril. 2016 Apr-Jun;10(1):11-21. (PMID: 27123195)
      PLoS Genet. 2014 May 15;10(5):e1004383. (PMID: 24830394)
      Bioinformatics. 2019 Nov 1;35(22):4851-4853. (PMID: 31233103)
      Nature. 2021 Aug;596(7872):393-397. (PMID: 34349265)
      Reprod Biol. 2023 Jun;23(2):100733. (PMID: 36821944)
      Stat Med. 2021 Nov 10;40(25):5434-5452. (PMID: 34338327)
      Stat Med. 2016 May 20;35(11):1880-906. (PMID: 26661904)
      Wellcome Open Res. 2019 Nov 26;4:186. (PMID: 32760811)
      Arch Gynecol Obstet. 2008 May;277(5):389-93. (PMID: 17922285)
      BMC Med. 2022 Nov 1;20(1):419. (PMID: 36320039)
      Hum Reprod. 2023 Aug 1;38(8):1520-1528. (PMID: 37403272)
      Fertil Steril. 2012 Sep;98(3):702-712.e6. (PMID: 22728052)
      Obstet Gynecol. 1995 Jun;85(6):983-92. (PMID: 7770271)
      Hum Reprod Update. 2019 Sep 11;25(5):592-632. (PMID: 31318420)
      BJOG. 2021 Mar;128(4):657-665. (PMID: 32757329)
      J Epidemiol Community Health. 1995 Feb;49(1):61-4. (PMID: 7707008)
      Nat Genet. 2018 May;50(5):693-698. (PMID: 29686387)
      Reprod Biomed Online. 2023 Sep;47(3):103186. (PMID: 37429766)
      Endocr Rev. 2023 Nov 9;44(6):1074-1095. (PMID: 37409951)
      Nature. 2023 Jan;613(7944):508-518. (PMID: 36653562)
      Best Pract Res Clin Obstet Gynaecol. 2018 Aug;51:1-15. (PMID: 30017581)
      N Engl J Med. 2020 Mar 26;382(13):1244-1256. (PMID: 32212520)
      Arch Gynecol Obstet. 2022 Apr;305(4):977-984. (PMID: 34448039)
      Adv Anat Pathol. 2021 Jan;28(1):30-43. (PMID: 33044230)
      Am J Obstet Gynecol. 2013 Jun;208(6):451.e1-11. (PMID: 23454253)
      Fertil Steril. 2016 Oct;106(5):1264-1269. (PMID: 27343955)
      Obstet Gynecol. 2004 Nov;104(5 Pt 1):965-74. (PMID: 15516386)
      BJOG. 2021 Nov;128(12):1938-1948. (PMID: 34028167)
    • Contributed Indexing:
      Keywords: Mendelian randomization; endometriosis; menstruation; mode of delivery; ovulation; reproductive function
    • Publication Date:
      Date Created: 20240819 Date Completed: 20240819 Latest Revision: 20240820
    • Publication Date:
      20240820
    • Accession Number:
      PMC11327065
    • Accession Number:
      10.3389/fendo.2024.1328403
    • Accession Number:
      39157682